D. Gully

[3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.

Catherine Labbé‐Jullié, J. Botto, Magdalena Mas et al. · Molecular Pharmacology · 1995 · 53 citations

Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists

Martine Poncelet, Christiane Gueudet, D. Gully et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1994 · 34 citations

Behavioral Neuroscience, Neuroanatomy, Neurophysiology +12

Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non‐neuronal cells

Florence Oury-Donat, O. Thurneyssen, Nadine Gonalons et al. · British Journal of Pharmacology · 1995 · 29 citations · Full text

Cyclic Amp Formation, Cellular Physiology, Tumor Biology +21

Steroid effects on brain functions: an example of the action of glucocorticoids on central dopaminergic and neurotensinergic systems.

William Rostène, Alain Sarrieau, Arnaud Nicot et al. · PubMed · 1995 · 27 citations · Full text

Central Dopaminergic, Glucocorticoid, Social Sciences +21

Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth

Kazuhiro Iwase, B. Mark Evers, Mark R. Hellmich et al. · Surgical Oncology · 1996 · 25 citations

Oncology, Human Colon Cancer, Medicine +10